Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
PaperCitations, authors & open-access status
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 859 citations, 2023 year and green oa status.
859
Citations
2023
Year
green
OA Status